BLUX yields 0.96% · JNJ yields 3.36%● Live data
📍 BLUX pulled ahead of the other in Year 1
Combined, BLUX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BLUX + JNJ for your $10,000?
BLUX seeks growth of capital through investments in shares of unaffiliated ETFs. It provides exposure to the domestic equity market by actively managing a portfolio of funds primarily invested in US companies. To back its total market claim, the fund-of-funds is diversified by market-cap, allowing exposure to small-, mid-, and large-caps. There are no limitations on investment styles or other factor tilts such as growth, value, and quality. In selecting constituents, the fund utilizes a combination of top-down and bottom-up investment approach to identify securities believed to be reasonable representatives, priced fairly, and reflects relative performance in comparison to similar ETFs. Note, however, that due to the funds active management, final investment decisions are at the discretion of the adviser, which may or may not include exposure to international securities.
Full BLUX Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.